Related Experiment Video
Updated: Sep 11, 2025

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Viral myocarditis in pediatrics: A review of current diagnostic methods and future directions
Iyas Dawood1, Samahir Taha Alhussein2, Wefag Yahya Adam Wadi3
1Faculty of Medicine, Omdurman Islamic University, Khartoum, Sudan.
Insights
Viral myocarditis, an inflammation of heart muscle in children, is increasingly linked to COVID-19. Early detection using advanced imaging and artificial intelligence (AI) is crucial for timely intervention and improved outcomes.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Medical Imaging
- Artificial Intelligence
Background:
- Viral myocarditis involves heart muscle inflammation due to viral infections, with a notable increase in pediatric cases.
- COVID-19 significantly elevates the risk of viral myocarditis in children, underscoring the need for vigilant monitoring.
- Current diagnostic methods like clinical exams and biomarkers often lack the necessary accuracy and specificity for early detection.
Purpose of the Study:
- To review current diagnostic modalities for viral myocarditis in pediatric patients.
- To highlight the potential of advanced imaging techniques and artificial intelligence (AI) in improving diagnostic accuracy and timeliness.
- To emphasize the importance of early detection for better patient outcomes and intervention strategies.
Main Methods:
- Review of clinical presentations, diagnostic imaging (Cardiac Magnetic Resonance, Point-of-Care Ultrasound, Positron Emission Tomography), and biomarkers.
- Evaluation of the role of Artificial Intelligence (AI) in interpreting imaging studies and reducing diagnostic bias.
- Discussion of genetic factors influencing susceptibility and potential therapeutic targets.
Main Results:
- Cardiac Magnetic Resonance (CMR) and Point-of-Care Ultrasound (POCUS) show promise for early detection of viral myocarditis.
- AI demonstrates potential to enhance diagnostic accuracy, reduce interpretation bias, and expedite the diagnostic process.
- Endomyocardial biopsy remains the gold standard but is invasive and not suitable for early screening.
Conclusions:
- Integrating AI with advanced imaging techniques offers a promising avenue for early and accurate diagnosis of pediatric viral myocarditis.
- Further research and collaborative efforts, including telemedicine, are essential to optimize AI-driven diagnostic tools for pediatric myocarditis.
- Genetic insights may pave the way for targeted therapies to mitigate disease progression in susceptible children.
Abstract:
Viral myocarditis is the inflammation of heart myocytes resulting from viral infection. Incidence in the pediatric population could reach 2 per 100,000 per year, and COVID-19 infection is a significant risk factor, which increases the possibility of having an infection by 40 times. Early detection results in catching the disease early and consequently improves outcomes. Clinical presentation of viral myocarditis in children could vary from mild prodromal symptoms to severe heart failure. Clinical examination, electrocardiogram, and chest X-ray may give clues for physiological and structural signs usually associated with the disease. However, they are inconclusive as they lack both accuracy and specificity. Biomarkers used to track the disease usually lack sensitivity and specificity. Cardiac magnetic resonance (CMR) is the imaging of choice to diagnose viral myocarditis by showing edema and late gadolinium enhancement. Point-of-care ultrasound has been approved as a good imaging method for early detection. It can be used as an effective screening tool for high-risk patients. Positron emission tomography scan is very sensitive in detecting disease early in its acute phase, especially if combined with CMR. All imaging studies are prone to interpretation bias, leading to a misdiagnosis. Endomyocardial biopsy is the gold standard method for diagnosis. However, it is time-consuming and ineffective as an early detection tool. Artificial intelligence (AI) helps with interpretation, decreasing bias, improving accuracy, and saving time and manpower. With more research and evidence, adopting AI-based methods to diagnose myocarditis in pediatrics could offer early detection, reduce costs, and save time for early intervention. Genetics helps identify inflammatory pathways involved in vulnerable patients, and genetic therapy may suppress disease progression by mitigating these pathways. Research focused on children is highly encouraged, and collaboration between healthcare institutions to develop telemedicine-based programs is influential.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis IV: Nursing Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies

